Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN on The Power Play to dicuss Phase 2b Ifenprodi study

View:

Post by StockHawk1 on Jan 16, 2023 6:01pm

AGN on The Power Play to dicuss Phase 2b Ifenprodi study

Algernon Pharmaceuticals (AGN.c AGNPF) featured on The Power Play after announcing plans for a Phase 2b clinical study of their Ifenprodi drug for chronic cough. AGN plans to start the 180-patient 90-day study in Q3. Results from Phase 2a were promising, so this could be a big catalyst for AGN.